Analyst Consensus
- Current Price
- 379.40 $
- Target (Low)
- 400.00 $
- Target (Mean)
- 561.39 $
- Target (High)
- 870.00 $
- Recommendation
- Strong Buy
- Number of Analysts
- 55
Recommendation Distribution
Recommendation Distribution| Strong Buy | 13 |
|---|
| Buy | 40 |
|---|
| Hold | 3 |
|---|
| Sell | 0 |
|---|
| Strong Sell | 0 |
|---|
Key Ratios
- Net Profit Margin
- 39.3%
- Operating Margin
- 46.3%
- Gross Margin
- 68.3%
- Return on Equity (ROE)
- 34.0%
- Return on Assets (ROA)
- 14.8%
- Revenue Growth
- 18.3%
- Earnings Growth
- 23.4%
- Debt/Equity
- 30.27
- Current Ratio
- 1.28
- Beta
- 1.10
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Jun 4, 2026 | TD Cowen | Buy → Buy |
| Jun 4, 2026 | Cantor Fitzgerald | Overweight → Overweight |
| Jun 4, 2026 | Citizens | Market Outperform → Market Outperform |
| Jun 1, 2026 | Wells Fargo | Overweight → Overweight |
| Jun 1, 2026 | Citizens | Market Outperform |
| May 13, 2026 | Wedbush | Outperform → Outperform |